Abstract
In California, molecular testing was useful in decreasing suspicion for severe acute respiratory syndrome (SARS), by detecting common respiratory pathogens (influenza A/B, human metapneumovirus, picornavirus, Mycoplasma pneumoniae, Chlamydia spp., parainfluenza virus, respiratory syncytial virus, and adenovirus) in 23 (45%) of 51 patients with suspected SARS and 9 (47%) of 19 patients with probable SARS.
MeSH terms
-
Antibodies, Viral / blood
-
California
-
Humans
-
RNA, Viral / chemistry
-
RNA, Viral / genetics
-
Respiratory Tract Infections / diagnosis*
-
Respiratory Tract Infections / virology
-
Reverse Transcriptase Polymerase Chain Reaction
-
Severe Acute Respiratory Syndrome / diagnosis*
-
Severe Acute Respiratory Syndrome / virology
-
Severe acute respiratory syndrome-related coronavirus / isolation & purification
-
Virus Diseases / diagnosis*
-
Virus Diseases / virology
Substances
-
Antibodies, Viral
-
RNA, Viral